Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Inspire Medical Systems, Inc. (INSP)
|
Add to portfolio |
|
|
Price: |
$232.65
| | Metrics |
OS: |
27.6
|
M
| |
|
|
Market cap: |
$6.43
|
B
| |
|
|
Net cash:
|
$442
|
M
| |
$15.98
|
per share
|
EV:
|
$5.99
|
B
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($40.2)
|
M
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-05-18 | Dec-31-17 | Dec-31-16 |
Revenues | 407.9 | 233.4 | 115.4 | 82.1 | 50.6 | 50.6 | 28.6 | 16.4 |
Revenue growth | 74.7% | 102.3% | 40.6% | 62.2% | 77.1% | | 73.9% | 105.0% |
Cost of goods sold | 66.1 | 33.3 | 17.6 | 13.6 | 10.1 | 10.1 | 6.0 | 3.9 |
Gross profit | 341.7 | 200.1 | 97.8 | 68.4 | 40.5 | 40.5 | 22.5 | 12.5 |
Gross margin | 83.8% | 85.7% | 84.7% | 83.4% | 80.1% | 80.1% | 78.9% | 76.2% |
Selling, general and administrative | 320.7 | 202.6 | 127.9 | 90.5 | 53.5 | 53.5 | 32.4 | 22.7 |
Research and development | 68.6 | 37.4 | 26.1 | 12.8 | 7.4 | 7.4 | 6.2 | 7.1 |
EBIT | -47.6 | -39.9 | -56.2 | -34.9 | -20.4 | -20.4 | -16.0 | -17.3 |
EBIT margin | -11.7% | -17.1% | -48.7% | -42.5% | -40.3% | -40.3% | -56.0% | -105.0% |
Pre-tax income | -44.3 | -42.0 | -57.1 | -33.2 | -21.8 | -21.8 | -17.5 | -18.5 |
Income taxes | 0.6 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | | | | | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -44.9 | -42.0 | -57.2 | -33.2 | -21.8 | -21.8 | -17.5 | -18.5 |
Net margin | -11.0% | -18.0% | -49.6% | -40.5% | -43.1% | -43.1% | -61.3% | -112.8% |
|
Diluted EPS | ($1.60) | ($1.54) | ($2.19) | ($1.40) | ($1.50) | ($1.50) | ($14.88) | ($16.90) |
Shares outstanding (diluted) | 28.1 | 27.3 | 26.1 | 23.8 | 14.6 | 14.6 | 1.2 | 1.1 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|